C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2011
06/09/2011	US20110135598 Methods to diagnose and immunize against the virus causing human merkel cell carcinoma
06/09/2011	US20110135596 Fusion protein comprising ubiquitin or ubiquitin-like protein, membrane translocation sequence and biologically active molecule and use thereof
06/09/2011	US20110135595 Neuregulin based methods and compositions for treating cardiovascular disease
06/09/2011	CA2783107A1 Malaria vaccines based on apicomplexan ferlins, ferlin-like proteins and other c2-domain containing proteins
06/09/2011	CA2782814A1 Binding proteins that bind to human fgfr1c, human .beta.-klotho and both human fgfr1c and human .beta.-klotho
06/09/2011	CA2782424A1 Factor viii-fc chimeric and hybrid polypeptides, and methods of use thereof
06/09/2011	CA2782406A1 Atoxic recombinant holotoxins of clostridium difficile as immunogens
06/09/2011	CA2781656A1 Human sweet taste receptor-acting sweet taste regulating substance to sweet taste substance
06/08/2011	EP2330221A1 Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma
06/08/2011	EP2330207A2 Transgenic plant-based methods for plant pests using RNAi
06/08/2011	EP2330206A1 A gene from Solanum bulbocastanum conferring resistance to Phytophthora infestans
06/08/2011	EP2330200A2 Gene expression technique
06/08/2011	EP2330198A1 IL-1 related polypeptides
06/08/2011	EP2330197A2 Antagonistic selective binding agents of osteoprotegerin binding protein
06/08/2011	EP2330192A1 Polypeptides and polynucleotides from coagulase-negative staphylococci
06/08/2011	EP2330188A1 Circovirus sequences associated with porcine wasting disease (PWD)
06/08/2011	EP2330186A2 Method for synthesizing protein containing high content of specific amino acid through simultaneous expression with trna of the specific amino acid
06/08/2011	EP2330127A2 Kallikrein-inhibiting Kunitz Domain proteins and nucleic acids encoding the same
06/08/2011	EP2330126A1 Protracted exendin-4 compounds
06/08/2011	EP2330125A2 Hybrid polypeptides with selectable properties
06/08/2011	EP2330124A2 Hybrid polypeptides with selectable properties
06/08/2011	EP2330123A2 HIV resistance genes
06/08/2011	EP2330122A1 OFA/iLRP derived modified peptide
06/08/2011	EP2330121A2 Binding moieties based on Shark IgNAR domains
06/08/2011	EP2330120A2 Binding moieties based on Shark IgNAR domains
06/08/2011	EP2330119A2 Methods for obtaining thermostable enzymes, DNA polymerase I variants from thermus aquaticus having new catalytic activities, methods for obtaining the same, and applications of the same
06/08/2011	EP2330118A1 Gene conferring resistance to Phytophthora infestans (late-blight) in solanaceae
06/08/2011	EP2330117A1 Genes of an otitis media isolate of nontypeable Haemophilus influenzae
06/08/2011	EP2330116A1 Replikin peptides and uses thereof
06/08/2011	EP2330115A1 Replikin peptides and uses thereof
06/08/2011	EP2330114A1 Glycoprotein production method and screening method
06/08/2011	EP2330113A1 Immunological methods and compositions for the treatment of Alzheimer's disease
06/08/2011	EP2330111A2 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
06/08/2011	EP2329846A1 Genetically engineered co-expression DNA vaccines, construction methods and uses thereof
06/08/2011	EP2329844A1 Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use
06/08/2011	EP2329841A1 Survivin peptide vaccine
06/08/2011	EP2329840A1 Survivin peptide vaccine
06/08/2011	EP2329838A2 Mutated netrin 4, fragments thereof and uses thereof as drugs
06/08/2011	EP2329837A1 Promoting bone growth
06/08/2011	EP2329273A1 Stable cell clone expressing a prion
06/08/2011	EP2329026A2 Method for the identification of genes involved in neurodegenerative processes
06/08/2011	EP2329025A1 Periostin-induced pancreatic regeneration
06/08/2011	EP2329023A1 Compositions and methods for delivery of protein-coding rnas to correct mitochondrial dysfunction
06/08/2011	EP2328928A2 Conserved influenza hemagglutinin epitope and antibodies thereto
06/08/2011	EP2328925A1 Peptides and peptidomimetic compounds, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
06/08/2011	EP2328924A2 Use of agonists of integrin alpha 5 for inducing the osteogenic differentiation of mesenchymal stem cells
06/08/2011	EP2328923A2 Cd133 epitopes
06/08/2011	EP2328922A2 Analogues of glucose-dependent insulinotropic polypeptide
06/08/2011	EP2328921A2 Methods and compositions for treating prostate cancer or inducing a humoral immune response against prostate cancer
06/08/2011	EP2328920A2 Targeted costimulatory polypeptides and methods of use to treat cancer
06/08/2011	EP2328919A2 Pd-i antagonists and methods for treating infectious disease
06/08/2011	EP2328918A1 Mutant alpha-synuclein, and methods using same
06/08/2011	EP2328917A1 Neuronal viability factor and use thereof
06/08/2011	EP2328916A1 Nematode-resistant transgenic plants
06/08/2011	EP2328915A2 Novel recombinant 15-kda polypeptide and use of same in detecting human infection with bartonella henselae
06/08/2011	EP2328914A1 Prevention, treatment and diagnosis of p.gingivalis infection
06/08/2011	EP2328913A2 Antimicrobial protein compositions and production therefor from marine bacteria
06/08/2011	EP2328912A1 Elisa assay for detecting antibodies against blv surface antigen gp 51 in bovine serum
06/08/2011	EP2328911A1 Short-form human md-2 as a negative regulator of toll-like receptor 4 signaling
06/08/2011	EP2328909A1 Human catechol-o-methyltransferase (comt) assay
06/08/2011	EP2328908A2 Treatment of amyloidoses using myelin basic protein and fragments thereof
06/08/2011	EP2328623A1 Method for reducing the viral and microbial load of biological extracts containing solids
06/08/2011	EP2328622A1 Radiolabeled annexins
06/08/2011	EP2328604A1 The use of wnt5-a peptide derivates for the treatment of melanoma and gastric cancer
06/08/2011	EP2328600A1 Hig2 and urlc10 epitope peptide and vaccines containing the same
06/08/2011	EP2328567A2 Continuous fiber layer comprising an active substance on the basis of bio-polymers, the use thereof, and method for the production thereof
06/08/2011	EP2328404A1 Resistance genes
06/08/2011	EP2021357B1 Cyclodipeptide synthetases and their use for synthesis of cyclo(leu-leu) cyclodipeptide
06/08/2011	EP1954811B1 Inducible expression systems
06/08/2011	EP1915389B1 Differentially protected orthogonal lanthionine technology
06/08/2011	EP1817584B1 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (pth) 1-84
06/08/2011	EP1786445B1 Live microbial microbicides
06/08/2011	EP1707629B1 Expression system using mammalian beta-actin promoter
06/08/2011	EP1694271B1 Fsh glycosylation mutant
06/08/2011	EP1573022B1 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
06/08/2011	EP1570269B1 Methods of protecting against radiation damage using alpha thymosin
06/08/2011	EP1527346B1 Modulation of platelet adhesion based on the surface exposed beta-switch loop of platelet glycoprotein ib-alpha
06/08/2011	EP1502599B1 Use of mutated VEGF for antiangiogenic therapy
06/08/2011	EP1276765B1 Single-chain fertility hormones with variable lh activity
06/08/2011	EP1078093B1 Vaccines, immunotherapeutics and methods for using the same
06/08/2011	EP0914142B1 Peptides with increased binding affinity for at least three hla-a3-like molecules
06/08/2011	CN1997665B Novel carbamylated EPO and method for its production
06/08/2011	CN1852736B Immunoglobulin chimeric monomer-dimer hybrids
06/08/2011	CN102089659A Abeta-oligomer measurement method
06/08/2011	CN102089432A Soluble recombinant influenza antigens
06/08/2011	CN102089324A Compositions and methods for the therapy and diagnosis of influenza
06/08/2011	CN102089323A Modulators of MYC, methods of using the same, and methods of identifying agents that modulate MYC
06/08/2011	CN102089322A Recombinant fibrinogen
06/08/2011	CN102089321A Somatostatin receptor 2 antagonists
06/08/2011	CN102089320A Lytic domain fusion constructs and methods of making and using same
06/08/2011	CN102089051A Amphiphilic proteins as morphology modifiers
06/08/2011	CN102089010A Dicabba-analogues of octreotide
06/08/2011	CN102089008A Manufacturing method of collagen gel composition for bone regeneration
06/08/2011	CN102089001A Immunity-inducing agent and method for detection of cancer
06/08/2011	CN102088995A Use of angiogenin or angiogenin agonists for treating diseases and disorders
06/08/2011	CN102088866A Soluble canola protein isolate production
06/08/2011	CN102088862A Angiogenin-enriched milk fractions
06/08/2011	CN102086458A Genes of wetland oilphilic pseudomonas strains and application thereof
06/08/2011	CN102086457A Genes of wetland oilphilic pseudomonas strains and application thereof
06/08/2011	CN102086456A Gene of swamp oleophilic Alcaligenes and application thereof

1 ... 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 ... 2916